Your session is about to expire
Coartem vs Malarone
Introduction
For patients who are at risk or have been diagnosed with malaria, certain medications can help in preventing the disease or managing its symptoms. Coartem and Malarone are two such drugs that are prescribed for malaria. Both of these antimalarial drugs work by killing the malaria parasite Plasmodium, but they do so in slightly different ways due to their composition.
Coartem contains artemether and lumefantrine which interfere with the growth cycle of the malarial parasite within human red blood cells, thereby stopping further infection.
On the other hand, Malarone is a combination of atovaquone and proguanil hydrochloride. Atovaquone interferes with reproduction and energy production process of parasites while Proguanil primarily inhibits dihydrofolate reductase enzyme which is crucial for DNA synthesis in parasites.
Both medicines have proven effective against various strains of malaria; however, their side effects differ as well as dosing regimen and drug-resistance patterns.
Coartem vs Malarone Side By Side
| Attribute | Coartem | Malarone |
|---|---|---|
| Brand Name | Coartem | Malarone |
| Contraindications | Severe vomiting or diarrhea, irregular heartbeat, dark urine, jaundice, interaction with rifampin, tetracycline antibiotics, and medicines for tuberculosis | Severe vomiting or diarrhea, irregular heartbeat, dark urine, jaundice, interaction with rifampin, tetracycline antibiotics, and medicines for tuberculosis |
| Cost | Around $200 for 24 tablets | Approximately $90-$115 for 12 tablets |
| Generic Name | Artemether/Lumefantrine | Atovaquone/Proguanil |
| Most Serious Side Effect | Symptoms indicative of liver damage, severe reactions affecting the nervous system | Signs of an allergic reaction, abnormal bleeding or bruising, rapid heart rate, unusual behavior changes, severe dizziness, problems with coordination, seizures |
| Severe Drug Interactions | Rifampin, tetracycline antibiotics, medicines for tuberculosis | Rifampin, tetracycline antibiotics, medicines for tuberculosis |
| Typical Dose | Four tablets per dose, taken twice daily for three days for adults and children over 35kg | One adult tablet (250 mg atovaquone/100 mg proguanil) daily for adults |
What is Coartem?
Artemether/lumefantrine, the generic name for Coartem, was a significant breakthrough in the antimalarial drug class. It was first approved by the FDA in 2009. Coartem disrupts the growth of malaria parasites in red blood cells, providing an effective treatment for most strains of malaria. It is prescribed generally as a short-term medication to treat acute cases of uncomplicated Plasmodium falciparum malaria.
Atovaquone/proguanil hydrochloride (Malarone) has been available since 2000 and is used both as a preventative measure and to treat uncomplicated cases of P. falciparum malaria. Unlike Coartem, Malarone inhibits two pathways involved in the biosynthesis of pyrimidines required for nucleic acid replication during parasite multiplication; resulting it being effective against malarial strains resistant to other drugs.
Each drug presents its own side effects: while nausea and vomiting are common with Malarone, headaches are more frequently associated with Coartem use.
What conditions is Coartem approved to treat?
Coartem and Malarone are both approved for the treatment of different forms of malaria:
- Coartem is primarily used to treat uncomplicated cases of Plasmodium falciparum, the most dangerous species that can result in severe illness or death.
- Malarone is typically used as a preventative measure against all types of malaria, including P. falciparum, and it's also effective in treating acute, uncomplicated cases caused by this parasite.
How does Coartem help with these illnesses?
Coartem helps to manage malaria by inhibiting the growth of plasmodium parasites within red blood cells. It does this through a combination of two drugs, artemether and lumefantrine, which work together to kill the parasite at different stages in its life cycle. Artemether rapidly reduces the number of parasites during the initial phase of infection while lumefantrine works more slowly but for a prolonged period, effectively clearing remaining parasites from the body. Plasmodium is a genus of parasitic protozoans that includes species causing malaria in humans. Malaria can result in severe physical symptoms like fever, chills and anemia among others. Thus by reducing and eliminating these parasites, Coartem can limit the negative effects of malaria and help patients manage their condition.
What is Malarone?
Malarone is a brand name for a combination of atovaquone and proguanil, which are used in the treatment and prevention of malaria. This drug works by inhibiting the reproduction process of the malarial parasite within red blood cells. Malarone was first approved by the FDA in 2000. It's not just another antimalarial medication; it has unique properties that set it apart from others like Coartem. The lack of action on pyrimethamine (a component common to many other antimalarials) means its side-effect profile might be different, particularly in terms of reduced chances for skin rashes or gastrointestinal upset—common reactions with other medications such as Coartem. Furthermore, Malarone can be taken daily rather than weekly, making it an attractive option for those traveling short term to high-risk areas or who have previously experienced troublesome side effects from traditional antimalarials.
What conditions is Malarone approved to treat?
Malarone is an antimalarial medication that has been approved for use in the United States by the FDA, and is often recommended for:
- Prevention of malaria. It's used particularly by travelers visiting areas where there is a high risk of P. falciparum malaria resistant to other prophylactic drugs.
- Treatment of acute, uncomplicated P. falciparum malaria when infection was acquired in areas where parasites may be resistant to other antimalarial drugs.
How does Malarone help with these illnesses?
Malarone is an antimalarial medication that works by interfering with the growth of parasites in the red blood cells of humans. These parasites are responsible for causing malaria when they are released into the bloodstream via mosquito bites. Malarone contains two active ingredients, proguanil and atovaquone, which work together to prevent the reproduction of these malarial parasites within your body. This coordinated action not only treats symptomatic malaria but also offers prophylactic protection against infection. While both Coartem and Malarone are effective treatments for malaria, Malarone has a broader spectrum of activity and can be used in areas where there is resistance to other antimalarials like Coartem. Additionally, unlike Coartem, Malarone does not require co-administration with food for optimal absorption making it more convenient to use during travel or situations where regular meals cannot be guaranteed.
How effective are both Coartem and Malarone?
Both Coartem (a combination of artemether and lumefantrine) and Malarone (a combination of atovaquone and proguanil) have proven successful in treating acute, uncomplicated malaria. They were initially approved by the FDA within a few years of each other. The mechanisms of action for these antimalarial medications differ: Coartem interferes with the growth cycle of the Plasmodium parasite that causes malaria inside human red blood cells, while Malarone inhibits two enzymes necessary for pyrimidine biosynthesis which is essential to parasite reproduction.
The efficacy of both drugs was compared in a double-blind clinical trial conducted in 2002; they demonstrated similar effectiveness in managing symptoms and clearing parasitemia, as well as comparable safety profiles. No significant differences were observed between patients receiving either drug regarding recovery times or side effects.
A review article from 2009 showed that Coartem starts alleviating symptoms effectively within the first 24 hours after treatment initiation due to its fast-acting component artemether. Its side effect profile is considered acceptable compared to many other antimalarials, despite common minor adverse events like headache or gastrointestinal issues, it's generally safe even if used during pregnancy from second trimester onwards.
On the other hand, according to a meta-analysis study published in 2015, Malarone not only appears effective against acute uncomplicated malaria but also provides preventive benefits when taken prophylactically before potential exposure to malarial parasites. It remains an important tool for travellers visiting endemic areas due to its convenient daily dosing regimen and favourable safety profile including less severe gastrointestinal side effects often associated with antimalarial drugs.
While both are effective treatments for malaria caused by all known strains of plasmodium species including multi-drug resistant P.falciparum , their use may be determined based on individual patient characteristics or regional resistance patterns among others factors; thus they could be chosen interchangeably depending upon specific circumstances related with each case.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Coartem typically prescribed?
Oral dosages of Coartem for adults and children weighing over 35kg consist of four tablets per dose, taken twice daily for three days. For children with a lower body weight, the dosage is adjusted accordingly. Studies have shown that this regimen is effective in treating most cases of uncomplicated malaria. On the other hand, Malarone is typically given once daily at a dosage determined by body weight: one tablet for those weighing more than 40kg, three-quarters of a tablet for those between 31-40kg, half a tablet for those between 21-30kg and one-quarter tablet for anyone under 20 kg. The treatment should start two days before potential exposure to malaria and continue seven days after leaving the area. Always consult your doctor or pharmacist before starting any new medication.
At what dose is Malarone typically prescribed?
Malarone treatment typically begins with a daily dosage of one adult tablet (250 mg atovaquone/100 mg proguanil) for adults. The dose can then be maintained throughout exposure to malaria and for 7 days after leaving the area. Dosing should start 1-2 days before travel to an area with malaria, continued daily during travel in the malarial area, and then for 7 days after leaving the region. For children's dosing, it depends on body weight; always consult a healthcare provider when determining doses for children. Malarone should ideally be taken with food or a milky drink to enhance absorption into your system. Like all medications, response and side effects vary among individuals.
What are the most common side effects for Coartem?
Common side effects of Coartem include:
- Headache
- Dizziness
- Weakness and fatigue
- Loss of appetite
- Nausea and vomiting, abdominal pain
- Palpitations (feeling your heart beat)
- Muscle and joint pain or stiffness
- Sleep disturbances including insomnia or abnormal dreams
- Coughing and difficulty breathing
On the other hand, Malarone may cause:
- Headache
- Nausea and vomiting, stomach pain
-Dizziness -Sleepiness/drowsiness or insomnia.
-Muscle aches or weakness. -Coughing.
Please consult with your healthcare provider if you experience any adverse effects after starting these medications.
Are there any potential serious side effects for Coartem?
When comparing Coartem to Malarone, it's important to be aware of potential side effects. While both drugs are generally safe when used as directed, there can be exceptions:
- An increase in unusual thoughts or behaviors
- Signs of an allergic reaction such as hives, difficulty breathing, swelling in your face or throat
- Eye problems like blurry vision, eye pain or swelling
- Rapid heartbeat or palpitations which may also accompany a feeling of light-headedness (as if you might faint)
- Low potassium levels that could lead to muscle weakness and cramps
- Severe reactions affecting the nervous system: muscle rigidity, high fever, sweating, confusion and tremors
- Symptoms indicative of liver damage: persistent nausea/vomiting/loss of appetite, stomach/abdominal pain on the upper right side), dark urine or yellowing eyes/skin
Both medications should only be taken under medical supervision and any adverse reactions must be reported promptly for appropriate intervention.
What are the most common side effects for Malarone?
Malarone, which is commonly used as a preventative measure against malaria may cause these side effects:
- Headache or dizziness
- Nausea, vomiting, stomach pain and loss of appetite
- Mild rash
- Insomnia or unusual dreams
- Coughing and stuffy nose
- Weakness or increased sensitivity to sunlight These are usually mild and temporary. It's important to weigh these potential side effects with the significant benefits of preventing malaria.
Are there any potential serious side effects for Malarone?
Malarone, like any other medicine, may cause side effects in some individuals. Serious reactions are rare but if you notice the following symptoms, consult your healthcare provider immediately:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling of your face, lips, tongue or throat
- Abnormal bleeding or bruising under the skin
- Rapid heart rate or palpitations
- Unusual behavior changes including confusion and hallucinations
- Severe dizziness leading to a risk of falls
- Problems with coordination causing unsteady movements
- Seizures (convulsions)
It's important to remember that this is not a complete list of potential side effects. If you experience any unusual symptoms after starting Malarone treatment for malaria prevention or treatment, it's best to seek immediate medical attention.
Contraindications for Coartem and Malarone?
Both Coartem and Malarone, like other antimalarial medications, may cause side effects in some individuals. If you notice symptoms such as severe vomiting or diarrhea, irregular heartbeat, dark urine or jaundice (yellowing of the skin or eyes), please seek immediate medical attention.
Neither Coartem nor Malarone should be taken if you are taking certain drugs that can interact negatively with them. These include rifampin, tetracycline antibiotics and medicines used to treat tuberculosis. Always inform your doctor about any other medications you are currently using; these potentially interacting drugs will require a period of clearance from your system to prevent dangerous interactions with Coartem and Malarone.
Furthermore, it's important to know that while both drugs work effectively against malaria caused by Plasmodium falciparum — the most deadly type of malaria parasite — they might not protect against all types of malaria parasites in all parts of the world. Therefore, it's essential to consult a healthcare professional for guidance on which medication is best suited for your specific travel destination.
How much do Coartem and Malarone cost?
For the brand name versions of these antimalarial drugs:
- The price of 24 tablets of Coartem (20/120 mg) averages around $200, which works out to about $50 per day for a typical four-day treatment.
- The price of 12 tablets of Malarone (250/100 mg) is approximately $90-$115, averaging around $7.5 - $9.6 per day for a typical dosage.
Considering this, if you are taking the standard adult dose for both medications (four tablets daily for Coartem and one tablet daily for Malarone), then brand-name Malarone is less expensive on a per-day treatment basis. It's important to remember that cost should not be your primary consideration in determining which drug to take; it's crucial also to consider potential side effects, contraindications and how effective each medication may be against the particular strain(s) of malaria found in your travel destination.
At present there are no generic versions available in U.S. market either for Coartem or Malarone, so costs remain relatively high compared with some other classes of medication.
Popularity of Coartem and Malarone
Artemether/lumefantrine, under brand names such as Coartem, is a common choice for the treatment of uncomplicated malaria in many parts of the world. In 2020 alone, millions of doses were distributed globally as part of efforts to combat malaria. The drug combination accounts for an important percentage of antimalarial prescriptions worldwide and has been steadily increasing in use since its introduction.
Atovaquone/proguanil, marketed under brand names like Malarone, is another commonly prescribed antimalarial drug for both prevention and treatment purposes. It was estimated that hundreds of thousands people took this medicine in high-risk areas throughout 2020. Despite its lower prescription volume compared to artemether/lumefantrine (Coartem), atovaquone/proguanil (Malarone) holds a significant market share within the realm of preventive antimalarials due to its efficacy and tolerability profile. The prevalence trend over recent years seems relatively steady with modest fluctuations based on epidemiological circumstances.
Conclusion
Both Coartem (artemether/lumefantrine) and Malarone (atovaquone/proguanil) are trusted treatments for malaria, backed by numerous clinical trials demonstrating their effectiveness over placebo. In some cases, the two may be used in sequence or even simultaneously; however, this should only occur under careful supervision from a medical professional due to possible drug interactions. The drugs function differently—Coartem acts by damaging the membranes of the parasites causing malaria while Malarone inhibits their reproduction—which can make them more suitable for different situations. For instance, Coartem is often used as a first-line treatment for uncomplicated Plasmodium falciparum malaria infections whereas Malarone might be chosen for its protective properties when traveling to regions with high risk of malaria.
Both medications have generic versions available which could mean significant cost savings particularly if patients need to pay out-of-pocket expenses. Both Coartem and Malarone could require an adjustment period where effects aren't immediately noticeable.
Side effects appear fairly comparable between both options—they're generally well-tolerated but stomach upset or headaches are common minor complaints. However, severe side effects like allergic reactions or liver problems must prompt immediate medical attention. It's crucial that any patient starting these therapies monitor their health closely and contact healthcare providers promptly if symptoms worsen or new issues arise.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Wernsdorfer, W. H. (2004, April). Coartemether (artemether and lumefantrine): an oral antimalarial drug. Expert Review of Anti-infective Therapy. Informa UK Limited.http://doi.org/10.1586/14787210.2.2.181
- Patel, S. N., & Kain, K. C. (2005, December). Atovaquone/proguanil for the prophylaxis and treatment of malaria. Expert Review of Anti-infective Therapy. Informa UK Limited.http://doi.org/10.1586/14787210.3.6.849
- Hamed, K., & Grueninger, H. (2012, June). Coartem<sup>®</sup>: a decade of patient-centric malaria management. Expert Review of Anti-infective Therapy. Informa UK Limited.http://doi.org/10.1586/eri.12.51